Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
D007516:Adenoma, Islet Cell / Q000188:drug therapy*; D000368:Aged; D005243:Feces / Q000032:analysis; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007583:Jejunum / Q000503:physiopathology; D008297:Male; D015282:Octreotide; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003969:Vipoma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D013004:Somatostatin; D015282:Octreotide